Skip to content
10-K

Annual Report

PALOMINO LABORATORIES INC. PALX

0001493152-26-014270

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 31, 2026 18.92M sh
Shares Diluted FY 2025 · Dec 31, 2025 6.71M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 1.52M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.28M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$4.87K
Cash And Equivalents FY 2025 · Dec 31, 2025 $8.12M
Cash And Equivalents FY 2025 · Dec 31, 2024 $134.66K
Stockholders Equity FY 2025 · Dec 31, 2025 $8.1M
Stockholders Equity restated FY 2025 · Dec 31, 2024 −$18.31K
Stockholders Equity FY 2025 · Mar 31, 2024 −$18.31K
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$2.11K
Current Liabilities FY 2025 · Dec 31, 2025 $336.46K
Current Liabilities restated FY 2025 · Dec 31, 2024 $6.43K
Total Liabilities FY 2025 · Dec 31, 2025 $336.46K
Total Liabilities restated FY 2025 · Dec 31, 2024 $156.43K
Current Assets FY 2025 · Dec 31, 2025 $8.43M
Current Assets restated FY 2025 · Dec 31, 2024 $138.13K
Total Assets FY 2025 · Dec 31, 2025 $8.43M
Total Assets restated FY 2025 · Dec 31, 2024 $138.13K
Eps Diluted FY 2025 · Dec 31, 2025 −$0.47
Eps Diluted restated FY 2025 · Dec 31, 2024 −$0.01
Eps Basic FY 2025 · Dec 31, 2025 −$0.47
Eps Basic FY 2025 · Sep 29, 2025 $0.75
Eps Basic restated FY 2025 · Dec 31, 2024 −$0.01
Sga Expense FY 2025 · Dec 31, 2025 $2.7M
Sga Expense restated FY 2025 · Dec 31, 2024 $6.12K
Net Income FY 2025 · Dec 31, 2025 −$3.16M
Net Income restated FY 2025 · Dec 31, 2024 −$16.2K
Operating Income FY 2025 · Dec 31, 2025 −$2.7M
Operating Income restated FY 2025 · Dec 31, 2024 −$6.12K